Oculis Holding AG (OCS) Non Operating Income (2022 - 2026)

Oculis Holding AG (OCS) recorded quarterly Non Operating Income of -$1.1 million in Q1 2026, up 70.71% quarter-over-quarter from -$3.8 million in Q4 2025, and down 569.4% on a YoY basis from $239133.9 in Q1 2025.

Oculis Holding AG (OCS) Non Operating Income (2022 - 2026) Analysis & Trends

Oculis Holding AG's Non Operating Income history runs 5 years deep, the most recent figure standing at -$1.1 million for Q1 2026.

  • In Q1 2026, Non Operating Income fell 569.4% year-over-year to -$1.1 million; the TTM figure through Mar 2026 stood at $6.9 billion (up 389.78% YoY), while the FY2025 annual figure was -$21.9 million, down 50.39% from the prior year.
  • Non Operating Income was -$1.1 million for Q1 2026 at Oculis Holding AG, up from -$3.8 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $6.9 billion in Q3 2025 to a low of -$2.4 billion in Q3 2024.
  • Historically, Non Operating Income has averaged $279.9 million across 5 years, with a median of -$1.7 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Non Operating Income tumbled 45430.84% in 2024, then jumped 391.6% in 2025.
  • A 5-year view of Non Operating Income shows it stood at $2.0 million in 2022, then plunged by 118.59% to -$369772.3 in 2023, then plunged by 3491.22% to -$13.3 million in 2024, then jumped by 71.14% to -$3.8 million in 2025, then soared by 70.71% to -$1.1 million in 2026.
  • The last three Non Operating Income figures came in at -$1.1 million (Q1 2026), -$3.8 million (Q4 2025), and $6.9 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - 5.75 Mn
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 444,000.00
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -
9 Abivax 90.15 Bn 90.15 Bn - 9.35 Mn
10 Oculis Holding AG 8.23 Bn 7.92 Bn - -1.12 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.12 Mn
Dec 31, 2025 -3.83 Mn
Sep 30, 2025 6.87 Bn
Jun 30, 2025 -5.59 Mn
Mar 31, 2025 239,133.87
Dec 31, 2024 -13.28 Mn
Sep 30, 2024 -2.36 Bn
Jun 30, 2024 1.85 Mn
Mar 31, 2024 -842,076.50
Dec 31, 2023 -369,772.27
Sep 30, 2023 -5.17 Mn
Jun 30, 2023 -2.24 Mn
Mar 31, 2023 -1.15 Mn
Dec 31, 2022 1.99 Mn
Sep 30, 2022 -3.18 Mn
Jun 30, 2022 -3.18 Mn